Digital Health and eConsent in Chinese Clinical Trials
Digital Health and eConsent in Chinese Clinical Trials How Digital Health and eConsent Are Transforming Clinical Trials in China Introduction The adoption of digital health technologies and electronic informed consent (eConsent) is reshaping the clinical trial landscape in China. With the National Medical Products Administration (NMPA) modernizing regulations and aligning with global best practices, sponsors…
Read More “Digital Health and eConsent in Chinese Clinical Trials” »